Skip to the main content

Review article

Management Guidelines for Allergic Rhinitis – The Role of Intranasal Corticosteroids

Gorazd Poje ; KBC Zagreb
Srećko Branica ; KBC Zagreb


Full text: croatian pdf 1.444 Kb

page 89-95

downloads: 7.328

cite


Abstract

Allergic rhinitis (AR) is the most common allergic disorder and its prevalence is still increasing. Before using the ARIA guidelines, about one third of patients with moderately severe / severe symptoms despite therapy had severe symptoms. The ARIA guidelines define AR as an inflammatory disease. Treatment of AR implies accurate assessment of disease severity, and any relationship of AR and asthma should be evaluated. Intranasal corticosteroids (ICS) are the most effective drugs in the treatment of AR with minimal risk of systemic side effects. ICS can be the first treatment option in all forms of AR because they treat all the symptoms of AR.

Keywords

allergic rhinitis; guidelines; intranasal corticosteroids

Hrčak ID:

111748

URI

https://hrcak.srce.hr/111748

Publication date:

5.11.2013.

Article data in other languages: croatian

Visits: 8.915 *